血液検査市場：製品タイプ、用途、エンドユーザー別-2025-2030年の世界予測

血液検査市場は、2023年に1,000億2,000万米ドルと評価され、2024年には1,060億1,000万米ドルに達すると予測され、CAGR 6.48％で成長し、2030年には1,553億1,000万米ドルに達すると予測されています。

血液検査市場には、病気の診断やモニタリング、健康状態の評価、治療方針の決定のために血液サンプルを用いて実施される幅広い検査室分析が含まれます。血液検査の必要性は、予防ヘルスケア、疾患の早期発見、治療モニタリング、精密医療における重要な役割から生じる。その用途は、血液学、内分泌学、腫瘍学、感染症学など、さまざまな分野に及んでいます。血液検査の1次エンドユーザーは、病院、診断研究所、研究機関、在宅医療の現場です。同市場は、慢性疾患の有病率の上昇、健康意識の高まり、在宅検査などの診断技術の進歩、スクリーニングプログラムを推進する政府の取り組みなどの成長要因から大きな影響を受けています。最近の動向は、迅速なポイントオブケア検査や低侵襲技術の開発とともに、データ分析や個別化医療のためのAIや機械学習の統合から生まれています。企業は、革新的な技術に焦点を当てた研究開発やバイオテクノロジー企業との戦略的提携に投資することで、こうした機会を捉えることができます。しかし、市場の成長は、厳しい規制の枠組み、高度な検査技術の高コスト、データ管理に関連するプライバシーの問題などの制約に直面しています。さらに、複雑な検査の実施と解釈に熟練した専門家が必要であることも、市場拡大の課題となっています。革新と研究は、先進地域と発展途上地域の両方におけるアクセシビリティを高めることができる、マイクロ流体やナノ診断プラットフォームのような、費用対効果が高く、迅速で正確な検査ソリューションの開発に向けられるのが最善です。市場は急速な技術進歩と競争力学を特徴としており、継続的な技術革新と新たな動向や課題への適応が必要です。競争力を維持するためには、企業は技術力や戦略的提携を強化するとともに、スケーラブルなソリューションの開発や、サービスが行き届いていない地域での地理的展開に注力すべきです。

市場力学：急速に進化する血液検査市場の主要市場インサイトを公開

血液検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 自己免疫疾患の有病率およびケア強化の必要性
  • 血液検査検診キャンペーンにおける政府の取り組み
  • 世界の血液検査施設の大幅な拡大
• 市場抑制要因
  • 原材料コストの変化と製品リコール問題
• 市場機会
  • 在宅ヘルスケアと遠隔医療の急速な普及
  • 血液検査製品の進歩
• 市場の課題
  • 皮膚穿刺の不正確さ、血液検査製品の安全性問題

ポーターのファイブフォース：血液検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、血液検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液検査市場における外部からの影響の把握

外部マクロ環境要因は、血液検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血液検査市場における競合情勢の把握

血液検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血液検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血液検査市場における成功への道筋を描く

血液検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個人における自己免疫疾患の有病率と強化ケアの必要性
    • 血液検査健康診断キャンペーンにおける政府の取り組み
    • 世界中で血液検査施設を大幅に拡張
  • 抑制要因
    • 原材料費の変動と製品リコールの問題
  • 機会
    • 在宅ヘルスケアと遠隔医療の急速な導入
    • 血液検査製品の進歩
  • 課題
    • 血液検査製品に関連する皮膚穿刺の不正確さと安全性の問題
• 市場セグメンテーション分析
  • タイプ：血液検査の基本代謝パネルの大幅な浸透
  • 応用：自己免疫疾患の診断における血液検査キットの使用増加
  • エンドユーザー：在宅ケアの現場における血液検査製品の普及の始まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血液検査市場：製品別

• 機器
• 試薬とキット
• ソフトウェア

第7章 血液検査市場テストタイプ別

• 基礎代謝パネル
• 全血球数検査
• 完全な代謝パネル
• 電解質パネル

第8章 血液検査市場：用途別

• アレルギー
• 自己免疫疾患
• がん/非がん性血液疾患
• 内分泌系疾患
• 心臓病

第9章 血液検査市場：エンドユーザー別

• 血液銀行
• 診断センター
• 病院・クリニック
• 病理学研究室

第10章 南北アメリカの血液検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の血液検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの血液検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • クエスト・ダイアグノスティクス、アルツハイマー病リスク評価と診断サポートのためのP-Tau217血液バイオマーカーを発表
  • バブソン・ダイアグノスティクス、革新的な小売ベースの血液検査サービスを開始
  • 日本のエーザイ、C2N Diagnosticsへの戦略的投資でアルツハイマー病の検出を強化
• 戦略分析と提言

企業一覧

• A. Menarini Diagnostics s.r.l.
• Abbott Laboratories
• ACON Laboratories, Inc.
• ARKRAY, Inc.
• B. Braun Melsungen AG
• Becton Dickinson & Company
• Bio-Rad Laboratories Inc.
• bioMerieux S.A.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Merck KGaA
• Nipro Corporation
• Nova Biomedical Corporation
• Novo Nordisk A/S
• Omnipod by Insulet Corporation
• Quest Diagnostic
• Randox Laboratories Ltd.
• Siemens AG
• Terumo Corporation
• Thermo Fisher Scientific, Inc.
• Trinity Biotech PLC
• Trividia Health, Inc.
• Ypsomed AG

LIST OF FIGURES

• FIGURE 1. BLOOD TESTING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Testing Market was valued at USD 100.02 billion in 2023, expected to reach USD 106.01 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 155.31 billion by 2030.

The blood testing market encompasses a wide range of laboratory analyses conducted on blood samples to diagnose and monitor diseases, assess health status, and guide treatment decisions. The necessity of blood testing arises from its crucial role in preventive healthcare, early disease detection, therapy monitoring, and precision medicine. Its applications extend across multiple disciplines, including hematology, endocrinology, oncology, and infectious diseases, among others. The primary end-users of blood testing are hospitals, diagnostics laboratories, research institutions, and homecare settings. The market is significantly influenced by growth factors such as the rising prevalence of chronic diseases, increasing health awareness, advancements in diagnostic technologies like home-based testing, and government initiatives promoting screening programs. Recent opportunities emerge from the integration of AI and machine learning for data analysis and personalized medicine, along with the development of rapid point-of-care testing and minimally invasive technologies. Companies can seize these opportunities by investing in R&D focused on innovative technologies and strategic partnerships with biotech firms. However, market growth faces limitations such as stringent regulatory frameworks, high costs of advanced testing technologies, and privacy concerns related to data management. Additionally, the need for skilled professionals to conduct and interpret complex tests can challenge market expansion. Innovations and research are best directed towards the development of cost-effective, rapid, and accurate testing solutions, like microfluidic and nano-diagnostic platforms, that can enhance accessibility in both developed and developing regions. The market is characterized by rapid technological advancements and competitive dynamics, necessitating continuous innovation and adaptation to emerging trends and challenges. To maintain a competitive edge, firms should focus on developing scalable solutions and expanding their geographical footprint in underserved regions, alongside enhancing their technological capabilities and strategic alliances.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Testing Market

The Blood Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of autoimmune disorders among individuals and need for enhanced care
  • Government initiatives in blood testing checkup campaigns
  • Significant expansion of blood testing facilities worldwide
• Market Restraints
  • Changing costs of raw materials and issues of product recalls
• Market Opportunities
  • Rapid adoption of home-based healthcare and telemedicine
  • Advancements in blood testing products
• Market Challenges
  • Inaccuracy in skin puncture and safety issues associated with blood testing products

Porter's Five Forces: A Strategic Tool for Navigating the Blood Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Testing Market

A detailed market share analysis in the Blood Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Testing Market

A strategic analysis of the Blood Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., bioMerieux S.A., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments, Reagents & kits, and Software.
• Based on Test Type, market is studied across Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels, and Electrolyte Panels.
• Based on Application, market is studied across Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders, Endocrine System Disorders, and Heart Diseases.
• Based on End-User, market is studied across Blood Banks, Diagnostic Centers, Hospital & Clinics, and Pathology Labs.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
    • 5.1.1.2. Government initiatives in blood testing checkup campaigns
    • 5.1.1.3. Significant expansion of blood testing facilities worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Changing costs of raw materials and issues of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
    • 5.1.3.2. Advancements in blood testing products
  • 5.1.4. Challenges
    • 5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
  • 5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
  • 5.2.3. End-User: Emerging penetration of blood testing products in home care settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Testing Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & kits
• 6.4. Software

7. Blood Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Basic Metabolic Panels
• 7.3. Complete Blood Count Tests
• 7.4. Complete Metabolic Panels
• 7.5. Electrolyte Panels

8. Blood Testing Market, by Application

• 8.1. Introduction
• 8.2. Allergies
• 8.3. Autoimmune Diseases
• 8.4. Cancer/Noncancerous Blood Disorders
• 8.5. Endocrine System Disorders
• 8.6. Heart Diseases

9. Blood Testing Market, by End-User

• 9.1. Introduction
• 9.2. Blood Banks
• 9.3. Diagnostic Centers
• 9.4. Hospital & Clinics
• 9.5. Pathology Labs

10. Americas Blood Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Blood Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Blood Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support
  • 13.3.2. Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service
  • 13.3.3. Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A. Menarini Diagnostics s.r.l.
• 2. Abbott Laboratories
• 3. ACON Laboratories, Inc.
• 4. ARKRAY, Inc.
• 5. B. Braun Melsungen AG
• 6. Becton Dickinson & Company
• 7. Bio-Rad Laboratories Inc.
• 8. bioMerieux S.A.
• 9. Danaher Corporation
• 10. F. Hoffmann-La Roche AG
• 11. Johnson & Johnson Services, Inc.
• 12. Medtronic PLC
• 13. Merck KGaA
• 14. Nipro Corporation
• 15. Nova Biomedical Corporation
• 16. Novo Nordisk A/S
• 17. Omnipod by Insulet Corporation
• 18. Quest Diagnostic
• 19. Randox Laboratories Ltd.
• 20. Siemens AG
• 21. Terumo Corporation
• 22. Thermo Fisher Scientific, Inc.
• 23. Trinity Biotech PLC
• 24. Trividia Health, Inc.
• 25. Ypsomed AG